Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced that it has commenced a $90 million underwritten public offering of shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE